Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Glantschnig, T; Koppelstatter, C; Zweiker, D; Kolesnik, E; Niederl, E; Kraler, E; Stoff, I; Zweiker, R; Weber, T; Horn, S; Weiss, T; Wang, W; Beaney, T; Poulter, NR; Perl, S.
May Measurement Month 2018-2019: an analysis of blood pressure screening results from Austria( )
EUR HEART J SUPPL. 2022; 24(SUPP F): F6-F8.
Doi: 10.1093/eurheartjsupp/suac038
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Glantschnig Theresa
-
Perl Sabine
- Co-Autor*innen der Med Uni Graz
-
Kolesnik Ewald
-
Niederl Ella
-
Zweiker David
-
Zweiker Robert
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Arterial hypertension is a global burden leading to over 10.8 million deaths per year worldwide. May Measurement Month (MMM) is a global project initiated by the International Society of Hypertension to raise the awareness of high blood pressure (BP) in the population. Following the MMM protocol 2508 participants >= 18 years had their BP measured in Austria in MMM18 and MMM19. Of those screened, 54.6% were found to be hypertensive, defined as a BP >= 140/90 mmHg and/or being on treatment for hypertension. Among those individuals with hypertension, 56.1% were on medication but only 42.0% of those treated had controlled BP (<140/90 mmHg). Lower BPs were found in those with previous myocardial infarction (MI), probably explained by a medical monitoring system of patients with MI in Austria. Those with hypertension were referred for further medical investigations and were provided lifestyle advice. Among a high number of individuals receiving antihypertensive treatment, BP is still not controlled. Further screening and monitoring of therapeutic effects is urgently required.
- Find related publications in this database (Keywords)
-
Hypertension
-
Blood Pressure
-
Screening
-
Treatment
-
Control